373
Participants
Start Date
May 24, 2023
Primary Completion Date
May 27, 2024
Study Completion Date
May 27, 2024
REGN9933
Participants will receive a single dose of REGN9933 by IV infusion
Enoxaparin
Participants will receive enoxaparin by SC administration daily through the time of venography (or day 12, whichever is earlier)
Apixiban
Participants will receive apixaban orally twice a day through the time of venography (or day 12, whichever is earlier)
Ziekenhuis Oost-Limburg- Campus Sint-Jan, Genk
MAV Korhaz es Rendelointezet Szolnok, Szolnok
MBAL Heart and Brain Hospital, Pleven
Department of Orthopedics, Somogy County Mór Kaposi Teaching Hospital, Kaposvár
Durham Bone and Joint Specialists, Ajax
Liepaja Regional Hospital, Liepāja
Vidzemes Hospital, Riga
Riga's 2nd Hospital, Riga
Hospital of Traumatology and Orthopaedics, Riga
Lietuvos Sveikatos Mokslu Universiteto Ligonine Kauno Klinik, Kaunas
Klaipeda University Hospital, Klaipėda
Lietuvos Sveikatos Mokslu Universiteto Kauno Ligoninė, Kaunas
Specjalistyczny Szpital im. E. Szczeklika w Tarnowie, Tarnów
SP ZOZ Centralny Szpital Kliniczny UM w Lodzi, Lodz
Samodzielny Publiczny Szpital Kliniczny nr 4 w Lublinie, Lublin
Samodzielny Publiczny Zaklad Opieki Zdrowotnej w Radzyniu Podlaskim, Radzyń Podlaski
Regeneron Pharmaceuticals
INDUSTRY